Autologous transplantation using high-dose radioimmunotherapy conditioning in patients 60 years and older.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 5, p. 372
- Publication type:
- Article
Works matching IS 15233790 AND DT 2007 AND VI 9 AND IP 5
Results: 18
1
2
Multidisciplinary management of special melanoma situations: Oligometastatic disease and bulky nodal sites.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 5, p. 417, doi. 10.1007/s11912-007-0057-5
- By:
- Publication type:
- Article
3
Management of metastatic melanoma patients with brain metastases.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 5, p. 411, doi. 10.1007/s11912-007-0056-6
- By:
- Publication type:
- Article
4
Unusual histologic and clinical variants of melanoma: Implications for therapy.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 5, p. 403, doi. 10.1007/s11912-007-0055-7
- By:
- Publication type:
- Article
5
Sentinel node biopsy or nodal observation.
- Published in:
- 2007
- By:
- Publication type:
- Report
6
Mantle cell lymphoma: Evolving novel options.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 5, p. 391, doi. 10.1007/s11912-007-0053-9
- By:
- Publication type:
- Article
7
Update on HIV lymphoma.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 5, p. 384, doi. 10.1007/s11912-007-0052-x
- By:
- Publication type:
- Article
8
Rituximab maintenance in indolent lymphoma: Indications and controversies.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 5, p. 378, doi. 10.1007/s11912-007-0051-y
- By:
- Publication type:
- Article
9
Therapy-related acute myelogenous leukemia and myelodysplastic syndrome.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 5, p. 373, doi. 10.1007/s11912-007-0050-z
- By:
- Publication type:
- Article
10
Enzastaurin, a Targeted PKCβ Inhibitor, in Relapsed or Refractory DLBCL: A Promising New Strategy Based on Gene Expression Signature.
- Published in:
- 2007
- By:
- Publication type:
- Report
11
The role of DNA repair in chronic lymphocytic leukemia pathogenesis and chemotherapy resistance.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 5, p. 361, doi. 10.1007/s11912-007-0048-6
- By:
- Publication type:
- Article
12
New treatments for chronic lymphocytic leukemia.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 5, p. 353, doi. 10.1007/s11912-007-0047-7
- By:
- Publication type:
- Article
13
Recognizing the toxicity of “Nontoxic” drugs employed in the management of malignant disease.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
14
Diagnosis and treatment of acute promyelocytic leukemia.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 5, p. 337, doi. 10.1007/s11912-007-0045-9
- By:
- Publication type:
- Article
15
Pentostatin, cyclophosphamide, and rituximab show significant clinical activity in patients with previously untreated chronic lymphocytic leukemia.
- Published in:
- 2007
- By:
- Publication type:
- Report
16
Web Alert.
- Published in:
- 2007
- Publication type:
- Editorial
17
Characterization of tumor specimens for a targeted therapy in metastatic renal cell carcinoma patients.
- Published in:
- 2007
- By:
- Publication type:
- Letter
18
Chronic lymphocytic leukemia: Biology and current treatment.
- Published in:
- Current Oncology Reports, 2007, v. 9, n. 5, p. 345, doi. 10.1007/s11912-007-0046-8
- By:
- Publication type:
- Article